Clévio Nobrega

Title: Clévio Nobrega: Innovator in Genetic Therapy

Introduction

Clévio Nobrega is a notable inventor based in Coimbra, Portugal. He has made significant contributions to the field of genetic therapy, particularly in the treatment of neurological disorders. His innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Clévio Nobrega holds a patent titled "Expression vector for cholesterol 24-hydrolase in therapy of polyglutamine repeat spinocerebellar ataxias." This invention relates to a vector designed for use in treating polyglutamine repeat spinocerebellar ataxia, which includes cholesterol 24-hydroxylase encoding nucleic acid. This patent represents a significant advancement in therapeutic approaches for this challenging condition. He has 1 patent to his name.

Career Highlights

Throughout his career, Clévio has worked with various esteemed organizations. Notably, he has been associated with Brainvectis and the Institut National de la Santé et de la Recherche Médicale. His work in these institutions has allowed him to further his research and contribute to advancements in medical science.

Collaborations

Clévio Nobrega has collaborated with several professionals in his field, including Sandro Alves and Nathalie Cartier-Lacave. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Clévio Nobrega is a pioneering inventor whose work in genetic therapy is making a difference in the treatment of neurological disorders. His contributions through patents and collaborations highlight his commitment to advancing medical science.